April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Accelerate transepithelial corneal collagen cross-linking for progressive keratoconus
Author Affiliations & Notes
  • Mauricio Rodriguez Diaz
    Ophtalmoogy, Instituto Oftalmosalud, Lima, Peru
  • Maria A Henriquez
    Ophtalmoogy, Instituto Oftalmosalud, Lima, Peru
  • Luis Izquierdo
    Ophtalmoogy, Instituto Oftalmosalud, Lima, Peru
  • Footnotes
    Commercial Relationships Mauricio Rodriguez Diaz, None; Maria Henriquez, None; Luis Izquierdo, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4219. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mauricio Rodriguez Diaz, Maria A Henriquez, Luis Izquierdo, ; Accelerate transepithelial corneal collagen cross-linking for progressive keratoconus. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4219.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the safety, efficacy, and stability of accelerate transepithelial corneal collagen crosslinking in progressive keratoconus.

Methods: This prospective study included 27 eyes of 27 patients with progressive keratoconus diagnosis whom underwent corneal collagen crosslinking between January 2013 and September 2013. The solution used was TE-riboflavin (Peschke Ltd, Germany) and the Ultraviolet-A treatment was performed with CCL-VARIO (Peschke Ltd, Germany) with 5 minutes of irradiation (18mW) and 30 minutes of impregnation. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), manifest refraction, demarcation line using anterior segment OCT (optical coherence tomography), and Scheimpflug imaging parameters where evaluated at pre and postoperatively day one, and 1, 3, 6 and 9 months.

Results: The mean crosslinking deep was 179.16 um at 1.5 mm from the center of the cornea, compared with 255.45 um at the center of the cornea. The mean diameter of the crosslinking was 3.63 mm visualized by AS-OCT. There was a not statistically significant difference between pre and postoperative pachymetry at the center and the thinnest point of the cornea (p > 0.05 in all visits). Mean maximum posterior elevation decrease from 36 um to 33.11 um (p = 0.09). Mean maximum keratometry at preoperative and postoperative follow up (3 month) was 50.21 and 50.75 diopters (D) respectively (p = 0.45). There was not complications during the follow up.

Conclusions: Accelerate transepithelial crosslinking is safe and efficacy to stop the progression of the keratoconus. AS-OCT images showed that the intended depth of crosslinking is achieved within the central area of the cornea.

Keywords: 574 keratoconus • 479 cornea: clinical science • 482 cornea: epithelium  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×